<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Aclaris Therapeutics, Inc. (ACRS) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/acrs/filings</link>
    <description>Latest company filings for Aclaris Therapeutics, Inc. (ACRS) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Mon, 13 Jul 2026 05:54:50 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/acrs/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[ACRS: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000121390026055376/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001213900-26-055376</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-12.]]></description>
      <pubDate>Tue, 12 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000110465926057202/acrs-20260331x10q.htm</link>
      <guid isPermaLink="false">0001104659-26-057202</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Quarterly report (10-Q) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000110465926056669/acrs-20260507x8k.htm</link>
      <guid isPermaLink="false">0001104659-26-056669</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Major company event (8-K) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000206526926000004/xslF345X06/form4-05052026_040505.xml</link>
      <guid isPermaLink="false">0002065269-26-000004</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-05-05.]]></description>
      <pubDate>Tue, 05 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000110465926049733/acrs-20260428x8k.htm</link>
      <guid isPermaLink="false">0001104659-26-049733</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Major company event (8-K) on 2026-04-28.]]></description>
      <pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000137360426000034/xslF345X06/form4.xml</link>
      <guid isPermaLink="false">0001373604-26-000034</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-04-27.]]></description>
      <pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000137360426000033/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001373604-26-000033</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-04-27.]]></description>
      <pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000110465926047264/acrs-20251231xars.pdf</link>
      <guid isPermaLink="false">0001104659-26-047264</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Annual report to shareholders (ARS) on 2026-04-23.]]></description>
      <pubDate>Thu, 23 Apr 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000110465926047263/acrs-20260423xdefa14a.htm</link>
      <guid isPermaLink="false">0001104659-26-047263</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Proxy materials (DEFA14A) on 2026-04-23.]]></description>
      <pubDate>Thu, 23 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000110465926047262/acrs-20260604xdef14a.htm</link>
      <guid isPermaLink="false">0001104659-26-047262</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Proxy statement (DEF 14A) on 2026-04-23.]]></description>
      <pubDate>Thu, 23 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[ACRS: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000134682426000099/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001346824-26-000099</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-04-07.]]></description>
      <pubDate>Tue, 07 Apr 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[ACRS: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000010290926000505/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000102909-26-000505</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-03-26.]]></description>
      <pubDate>Thu, 26 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ACRS: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000117266126001355/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001172661-26-001355</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-03-17.]]></description>
      <pubDate>Tue, 17 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000110465926026407/acrs-20260310x8k.htm</link>
      <guid isPermaLink="false">0001104659-26-026407</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-11.]]></description>
      <pubDate>Wed, 11 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000110465926025420/acrs-20260309x8k.htm</link>
      <guid isPermaLink="false">0001104659-26-025420</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-10.]]></description>
      <pubDate>Tue, 10 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000195755426000011/xslF345X05/form4-03032026_040301.xml</link>
      <guid isPermaLink="false">0001957554-26-000011</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000110465926020540/acrs-20251231x10k.htm</link>
      <guid isPermaLink="false">0001104659-26-020540</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Annual report (10-K) on 2026-02-26.]]></description>
      <pubDate>Thu, 26 Feb 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000110465926020070/acrs-20260226x8k.htm</link>
      <guid isPermaLink="false">0001104659-26-020070</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Major company event (8-K) on 2026-02-26.]]></description>
      <pubDate>Thu, 26 Feb 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ACRS: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000137360426000008/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001373604-26-000008</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-09.]]></description>
      <pubDate>Mon, 09 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000207632726000002/xslF345X05/form4-02062026_110219.xml</link>
      <guid isPermaLink="false">0002076327-26-000002</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-02-06.]]></description>
      <pubDate>Fri, 06 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000206526926000002/xslF345X05/form4-02062026_110246.xml</link>
      <guid isPermaLink="false">0002065269-26-000002</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-02-06.]]></description>
      <pubDate>Fri, 06 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000204502726000004/xslF345X05/form4-02062026_110205.xml</link>
      <guid isPermaLink="false">0002045027-26-000004</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-02-06.]]></description>
      <pubDate>Fri, 06 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000195755426000009/xslF345X05/form4-02062026_110245.xml</link>
      <guid isPermaLink="false">0001957554-26-000009</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-02-06.]]></description>
      <pubDate>Fri, 06 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000178154926000013/xslF345X05/form4-02062026_110255.xml</link>
      <guid isPermaLink="false">0001781549-26-000013</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-02-06.]]></description>
      <pubDate>Fri, 06 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000160445726000007/xslF345X05/form4-02062026_110224.xml</link>
      <guid isPermaLink="false">0001604457-26-000007</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-02-06.]]></description>
      <pubDate>Fri, 06 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000204502726000002/xslF345X05/form4-02052026_090256.xml</link>
      <guid isPermaLink="false">0002045027-26-000002</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-02-05.]]></description>
      <pubDate>Thu, 05 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000195755426000007/xslF345X05/form4-02052026_090243.xml</link>
      <guid isPermaLink="false">0001957554-26-000007</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-02-05.]]></description>
      <pubDate>Thu, 05 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000178154926000011/xslF345X05/form4-02052026_090237.xml</link>
      <guid isPermaLink="false">0001781549-26-000011</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-02-05.]]></description>
      <pubDate>Thu, 05 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (amended) (4/A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000178154926000009/xslF345X05/form4a-02052026_090200.xml</link>
      <guid isPermaLink="false">0001781549-26-000009</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (amended) (4/A) on 2026-02-05.]]></description>
      <pubDate>Thu, 05 Feb 2026 12:00:00 GMT</pubDate>
      <category>4/A</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000160445726000005/xslF345X05/form4-02052026_090254.xml</link>
      <guid isPermaLink="false">0001604457-26-000005</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-02-05.]]></description>
      <pubDate>Thu, 05 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000195755426000005/xslF345X05/form4-02032026_100245.xml</link>
      <guid isPermaLink="false">0001957554-26-000005</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-02-03.]]></description>
      <pubDate>Tue, 03 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000178154926000007/xslF345X05/form4-02032026_100229.xml</link>
      <guid isPermaLink="false">0001781549-26-000007</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-02-03.]]></description>
      <pubDate>Tue, 03 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (amended) (4/A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000178154926000005/xslF345X05/form4a-02032026_100202.xml</link>
      <guid isPermaLink="false">0001781549-26-000005</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (amended) (4/A) on 2026-02-03.]]></description>
      <pubDate>Tue, 03 Feb 2026 12:00:00 GMT</pubDate>
      <category>4/A</category>
    </item>
    <item>
      <title><![CDATA[ACRS: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000201238326000630/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0002012383-26-000630</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-01-21.]]></description>
      <pubDate>Wed, 21 Jan 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000110465926002694/acrs-20260112x8k.htm</link>
      <guid isPermaLink="false">0001104659-26-002694</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Major company event (8-K) on 2026-01-12.]]></description>
      <pubDate>Mon, 12 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ACRS: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000092963826000098/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000929638-26-000098</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-01-09.]]></description>
      <pubDate>Fri, 09 Jan 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000110465926001076/acrs-20260106x8k.htm</link>
      <guid isPermaLink="false">0001104659-26-001076</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Major company event (8-K) on 2026-01-06.]]></description>
      <pubDate>Tue, 06 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000195755426000003/xslF345X05/form4-01052026_090132.xml</link>
      <guid isPermaLink="false">0001957554-26-000003</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-01-05.]]></description>
      <pubDate>Mon, 05 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000178154926000003/xslF345X05/form4-01052026_090101.xml</link>
      <guid isPermaLink="false">0001781549-26-000003</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-01-05.]]></description>
      <pubDate>Mon, 05 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000160445726000003/xslF345X05/form4-01052026_090114.xml</link>
      <guid isPermaLink="false">0001604457-26-000003</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2026-01-05.]]></description>
      <pubDate>Mon, 05 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000204502725000003/xslF345X05/form4-12042025_091242.xml</link>
      <guid isPermaLink="false">0002045027-25-000003</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2025-12-04.]]></description>
      <pubDate>Thu, 04 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000090266425004888/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000902664-25-004888</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2025-11-13.]]></description>
      <pubDate>Thu, 13 Nov 2025 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000110465925107788/acrs-20250930x10q.htm</link>
      <guid isPermaLink="false">0001104659-25-107788</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Quarterly report (10-Q) on 2025-11-06.]]></description>
      <pubDate>Thu, 06 Nov 2025 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000110465925107353/acrs-20251106x8k.htm</link>
      <guid isPermaLink="false">0001104659-25-107353</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Major company event (8-K) on 2025-11-06.]]></description>
      <pubDate>Thu, 06 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000110465925098991/acrs-20251014x8k.htm</link>
      <guid isPermaLink="false">0001104659-25-098991</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Major company event (8-K) on 2025-10-14.]]></description>
      <pubDate>Tue, 14 Oct 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000155837025010789/acrs-20250630x10q.htm</link>
      <guid isPermaLink="false">0001558370-25-010789</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Quarterly report (10-Q) on 2025-08-07.]]></description>
      <pubDate>Thu, 07 Aug 2025 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000155837025010640/acrs-20250807x8k.htm</link>
      <guid isPermaLink="false">0001558370-25-010640</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Major company event (8-K) on 2025-08-07.]]></description>
      <pubDate>Thu, 07 Aug 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000141588925021045/xslF345X05/form4-08052025_080841.xml</link>
      <guid isPermaLink="false">0001415889-25-021045</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Insider trade (4) on 2025-08-05.]]></description>
      <pubDate>Tue, 05 Aug 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ACRS: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000141588925021040/xslF345X02/form3-08052025_080827.xml</link>
      <guid isPermaLink="false">0001415889-25-021040</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a New insider ownership (3) on 2025-08-05.]]></description>
      <pubDate>Tue, 05 Aug 2025 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[ACRS: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1557746/000155837025009739/acrs-20250729x8k.htm</link>
      <guid isPermaLink="false">0001558370-25-009739</guid>
      <description><![CDATA[Aclaris Therapeutics, Inc. filed a Major company event (8-K) on 2025-07-29.]]></description>
      <pubDate>Tue, 29 Jul 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
  </channel>
</rss>